10 x Tiromel T3 / Cytomel (1000 tabs)
New Bacth Tiromel (March, 2016) has bigger box. Same dosage, same box design, same tablet counts.
New batch Tiromel is in stock now. Product photos are attached to product images.
1000 tablets (10 boxes)
|Systemic Category:||Endocrine system drugs - Thyroid disturbances drugs|
Hormonal derivative drugs - Thyroid drugs - Thyroid hormones
Replacement therapy in hypothyroidism, Severe and chronic hypothyroidism, TSH suppression, Myxoedema coma
Untreated hyperthyroidism; uncorrected adrenal failure; recent MI.
Nervousness, excitability, tremor, muscle weakness, cramps; sweating, flushing, heat intolerance, headache, insomnia, tachycardia, palpitations, angina pectoris, excessive wt loss; menstrual irregularities; diarrhoea, vomiting. Potentially Fatal: Convulsions, cardiac arrhythmia, heart failure, coma.
Reduced absorption with iron, colestyramine, colestipol, aluminium- and magnesium-containing antacids, calcium carbonate, simethicone, sucralfate. May alter requirements of antidiabetic drugs. Reduced efficacy of thyroid replacement therapy with imatinib. Reduced tri-iodothyronine serum levels with amiodarone. Reduced serum levels of thyroxine with carbamazepine, phenytoin, phenobarbital, rifampicin, oestrogens. Potentially Fatal: Increased therapeutic and toxic effects of levothyroxine and TCAs. May change hypoprothrombinaemic response to warfarin and other oral anticoagulants (markedly increased response during replacement). Increased risk of significant hypertension and tachycardia with ketamine.
Angina, heart failure; DM; diabetes insipidus; elderly; long-standing hypothyroidism; adrenal insufficiency; myxoedema.
Tiromel by Abdi Ibrahim is a synthetically manufactured prescription thyroid hormone. It specially consists of the L-isomer of the natural thyroid hormone triiodothyronine (T3). Thyroid hormones stimulate basal metabolic rate, and are involved with many cellular functions including protein, fat, and carbohydrate metabolism. Tiromel by Abdi Ibrahim is used medically to treat hypothyroidism, a condition where the thyroid gland does not produce sufficient levels of thyroid hormone. Hypothyroidism is usually diagnosed with a serum hormone profile (T3, T4, & TSH), and may manifest itself with symptoms including loss of energy, lethargy, weight gain, hair loss, and changes in skin texture. T3 is the most active thyroid hormone in the body, and consequently Tiromel by Abdi Ibrahim is considered to be a more potent thyroid medication than levothyroxine sodium (T4).
Bodybuilders and athletes are attracted to Tiromel by Abdi Ibrahim for its ability to increase metabolism and support the breakdown of body fat. Most often utilized during contest preparation or periods of "cutting". Tiromel by Abdi Ibrahim is usually said to significantly aid in the loss of fat, often on higher levels of caloric intake than would normally be permissive of such fat loss. To this end, Tiromel by Abdi Ibrahim is also commonly used in conjunction with other fat loss agents such as human growth hormone or beta agonists. Some users also ascribe an ability of thyroid hormones like Tiromel by Abdi Ibrahim to increase the anabolic effect of steroids.
The usual protocol among bodybuilders and athletes taking Tiromel by Abdi Ibrahim to accelerate fat loss involves initiating its use with a dosage of 25 mcg per day. This dosage may be increased by 25 mcg every 4 to 7 days, usually reaching a maximum of no more than 75 mcg of Tiromel by Abdi Ibrahim per day. As in a medical setting, the intent of this slow buildup is to help the body become adjust to the increasing thyroid hormone levels, and avoid sudden changes that may initiate side effects. Cycles of Tiromel by Abdi Ibrahim usually last no longer than 6 weeks, and administration of Tiromel by Abdi Ibrahim should not be halted abruptly. Instead, Tiromel by Abdi Ibrahim is discontinued in the same slow manner in which it was initiated. This usually entails reducing the dosage by 25 mcg every 4 to 7 days. This tapering is done so that the body has time to readjust its endogenous hormone production at the conclusion of therapy, and to avoid the onset of side effects.